Palmitoyl Pentapeptide-4 (Matrixyl)

Palmitoyl Pentapeptide-4, widely known by the trade name Matrixyl, is a pioneering lipophilic signal peptide that revolutionized the anti-aging cosmetic industry. Developed by Sederma (France), it was the first peptide to demonstrate clinically significant wrinkle reduction comparable to retinoids, but without the associated irritation and photosensitivity. Matrixyl has become one of the most extensively studied and widely used anti-aging peptide ingredients in premium skincare formulations worldwide, with a robust body of clinical evidence supporting its efficacy.